Post-Earnings Pop Bad News for Intrexon Corporation (XON) Bears

Intrexon Corp (NYSE:XON) saw its price target reduced at Mizuho

May 12, 2015 at 11:02 AM
facebook twitter linkedin

Intrexon Corp (NYSE:XON) jumped out of the gate, after the company reported a first-quarter earnings beat, and a 331% increase in revenue from the same period last year. Despite a brief trek south of breakeven around 10:00 a.m. ET, the shares were last seen up 1.5% at $43.70. The generally well-received report is likely disappointing traders both in and out of the options arena.

Specifically, the equity's Schaeffer's put/call open interest ratio (SOIR) of 0.85 ranks in the 84th annual percentile. This reveals XON's short-term options traders to be more put-skewed than normal. Elsewhere, over 28% of XON's float is sold short, and would take more than two weeks to repurchase, at the stock's normal daily trading volumes.

On a long-term technical level, there's not much to dislike about Intrexon Corp (NYSE:XON). Since this time last year, the security has added over 170%. Still, Mizuho overnight cut its price target cut to $45 from $50. On the whole, though, analysts are behind the genetic engineering stock. XON's average 12-month price target of $56.25 marks a 34% premium to current levels, and sits in uncharted territory. Also, three-fourths of brokerage firms rate the shares a "strong buy."


Now is the time to join our thriving community of Event Traders who consistently profit from every earnings season. With this discounted subscription opportunity, you'll stay ahead of the curve and seize opportunities others miss. Do not let Q3 earnings season pass you by – subscribe now and supercharge your portfolio with expert insights that turn market reactions into profit-generating opportunities!! Don't waste another second... join us right now before the next trade targeting +200% is released!